Literature DB >> 17150178

Hyperactivity and alteration of the midbrain dopaminergic system in maternally stressed male mice offspring.

Gi Hoon Son1, Sooyoung Chung, Dongho Geum, Sang Soo Kang, Wan Sung Choi, Kyungjin Kim, Sukwoo Choi.   

Abstract

We recently demonstrated that prolonged maternal stress produces profound and long-lasting deficits in brain functions by programming a subset of target genes. We have now examined the possible effects of prenatal stress on the motility of adult offspring and dopamine (DA)-related gene expression in their midbrains, one of the target brain regions of stress hormones. Maternally stressed adult male mice showed impaired response habituation to novelty, and increased wheel-running activity associated with altered responses to DA receptor and DA transporter (DAT) blockers. Along with the behavioral changes, the expression profiles of several genes of the midbrain DAergic system appeared to be altered. Expression of DAT was reduced and expression of DA receptors and striatal DA-regulated neuropeptide genes was also affected. Taken together, the present findings indicate that maternal stress can cause hyperactivity in adult offspring associated with alterations in the midbrain DAergic system suggestive of a functional hyperdopaminergic state.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17150178     DOI: 10.1016/j.bbrc.2006.11.104

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Intergenerational transmission of self-regulation: A multidisciplinary review and integrative conceptual framework.

Authors:  David J Bridgett; Nicole M Burt; Erin S Edwards; Kirby Deater-Deckard
Journal:  Psychol Bull       Date:  2015-05       Impact factor: 17.737

Review 2.  Unravelling the Link Between Prenatal Stress, Dopamine and Substance Use Disorder.

Authors:  Verónica Pastor; Marta Cristina Antonelli; María Eugenia Pallarés
Journal:  Neurotox Res       Date:  2016-10-24       Impact factor: 3.911

3.  Prenatal stress-induced increases in placental inflammation and offspring hyperactivity are male-specific and ameliorated by maternal antiinflammatory treatment.

Authors:  Stefanie L Bronson; Tracy L Bale
Journal:  Endocrinology       Date:  2014-05-05       Impact factor: 4.736

4.  Prenatal amphetamine exposure effects on dopaminergic receptors and transporter in postnatal rats.

Authors:  Gonzalo Flores; María de Jesús Gómez-Villalobos; Leonardo Rodríguez-Sosa
Journal:  Neurochem Res       Date:  2011-05-25       Impact factor: 3.996

5.  Early life protein restriction alters dopamine circuitry.

Authors:  Z Vucetic; K Totoki; H Schoch; K W Whitaker; T Hill-Smith; I Lucki; T M Reyes
Journal:  Neuroscience       Date:  2010-04-13       Impact factor: 3.590

Review 6.  Models of neurodevelopmental abnormalities in schizophrenia.

Authors:  Susan B Powell
Journal:  Curr Top Behav Neurosci       Date:  2010

7.  Structure of distress call: implication for specificity and activation of dopaminergic system.

Authors:  Subramanian Mariappan; Wieslaw Bogdanowicz; Hanumanthan Raghuram; Ganapathy Marimuthu; Koilmani Emmanuvel Rajan
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2015-11-26       Impact factor: 1.836

8.  The impact of maternal neglect on genetic hyperactivity.

Authors:  Petra Majdak; Elizabeth L Grogan; Joseph V Gogola; Anastassia Sorokina; Stephen Tse; Justin S Rhodes
Journal:  Behav Brain Res       Date:  2016-07-19       Impact factor: 3.332

Review 9.  Prenatal stress and risk for autism.

Authors:  Dennis K Kinney; Kerim M Munir; David J Crowley; Andrea M Miller
Journal:  Neurosci Biobehav Rev       Date:  2008-06-13       Impact factor: 8.989

10.  Maternal exposure to nanoparticulate titanium dioxide during the prenatal period alters gene expression related to brain development in the mouse.

Authors:  Midori Shimizu; Hitoshi Tainaka; Taro Oba; Keisuke Mizuo; Masakazu Umezawa; Ken Takeda
Journal:  Part Fibre Toxicol       Date:  2009-07-29       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.